Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

Technology maturity: Technology has reached a level of maturity that allows integration of various systems and devices to be seamless. Connected health devices and cloud platforms have evolved from ...

An Institute for Value-Based Medicine ® event held in New Haven, Connecticut, on October 30, 2025, brought together a diverse ...

Wave Life Sciences' $3.5B valuation reflects both pipeline risk and opportunity. Click here to find out why WVE stock is a Hold.

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-m ...

Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Research highlights the complex cognitive difficulties faced by breast cancer survivors, emphasizing the need for ...

Health system CIOs are entering 2026 with a shared conviction: The industry’s next leap forward won’t come from adding more technology, but from scaling the right technology with discipline, ...

The Wearable Imaging for Transforming Elderly Care (WITEC) collaborative research project aims to develop the world's first ...

An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...

AI-native networks are unlocking new digital experiences that go far beyond connectivity. With embedded location-based technologies like Bluetooth Low Energy (BLE), health systems are improving ...